Third Arc Bio Funding & Investors
Philadelphia, PA
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases. Its drug development engine delivers superior biologics optimized to create T-cell engagement by leveraging two technologies that power a pipeline of high-value therapeutics β a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety.
thirdarcbio.comTotal Amount Raised: $165,000,000
Third Arc Bio Funding Rounds
Series A
$165,000,000
Series A Investors
Cormorant Asset ManagementHillhouse InvestmentVida VenturesLogos CapitalBVF PartnersabrdnJanus Henderson InvestorsAbbVieFreepoint Capital GroupMarshall WaceT. Rowe PriceGoldman Sachs AlternativesForesite CapitalOmega Fund Management
Funding info provided by Diffbot.